BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 6974194)

  • 41. Regulation of alloantigen-induced cytotoxic responses by concanavalin A-activated lymphoid cells: suppression by antigen elimination.
    Kastner DL; Rich RR
    J Immunol; 1978 Nov; 121(5):1732-7. PubMed ID: 712063
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of cytotoxic T-cell clonal expansion by cyclophosphamide and the recovery of cytotoxic T-lymphocyte precursors by supernatants from mixed-lymphocyte cultures.
    Merluzzi VJ; Walker MM; Faanes RB
    Cancer Res; 1981 Mar; 41(3):850-3. PubMed ID: 6450638
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phenotype of syngeneic tumor-specific cytotoxic T-lymphocytes and requirements for their in vitro generation from tumor-bearing host and immune spleens.
    Bear HD; Susskind BM; Close KA; Barrett SK
    Cancer Res; 1988 Mar; 48(6):1422-7. PubMed ID: 2964266
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Helper factor production in murine secondary syngeneic mixed leukocyte reactions.
    Zuberi RI; Altman A
    J Immunol; 1982 Feb; 128(2):817-22. PubMed ID: 6172511
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lymphocyte-mediated cytotoxicity against allogeneic tumour cells. IV. Fine specificity mapping and characterization of concanavalin A-activated cytotoxic effector lymphocytes.
    Waterfield JD; Nixon DF; Mair MG
    Immunology; 1981 Dec; 44(4):685-93. PubMed ID: 6797935
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Generation of cytotoxic lymphocytes to syngeneic tumor by using co-stimulator (Interleukin 2).
    Mills GB; Paetkau V
    J Immunol; 1980 Nov; 125(5):1897-903. PubMed ID: 6159395
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Helper cells in murine thymus for the generation of primary cytolytic T lymphocyte (CTL) responses in vitro.
    Wu S; Bach FH
    J Immunol; 1981 Feb; 126(2):775-80. PubMed ID: 6969763
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Costimulation with B7-1, IL-6, and IL-12 is sufficient for primary generation of murine antitumor cytolytic T lymphocytes in vitro.
    Gajewski TF; Renauld JC; Van Pel A; Boon T
    J Immunol; 1995 Jun; 154(11):5637-48. PubMed ID: 7538528
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dysfunction of irradiated thymus for the development of helper T cells.
    Amagai T; Kina T; Hirokawa K; Nishikawa S; Imanishi J; Katsura Y
    J Immunol; 1987 Jul; 139(2):358-64. PubMed ID: 2955040
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Macrophage T lymphocyte interactions in the anti-tumor immune response: a mathematical model.
    De Boer RJ; Hogeweg P; Dullens HF; De Weger RA; Den Otter W
    J Immunol; 1985 Apr; 134(4):2748-58. PubMed ID: 3156189
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Increase of proliferative and cytotoxic responses to alloantigenic stimulation of mouse spleen cells treated with aclacinomycin].
    Bravo-Cuéllar A; Martín-Ruíz JL; Ramos-Pineda R; Puebla-Pérez AM; Leal-Delgadillo A; Liu XH; Orbach-Arbouys S
    Arch Invest Med (Mex); 1990; 21(4):331-7. PubMed ID: 1669222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Precursor frequency analysis of bryostatin activated lymphocytes.
    Fleming MD; Barrett SK; Bear HD
    J Surg Res; 1994 Jul; 57(1):74-9. PubMed ID: 8041153
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Further characterization of thymic suppressor cells and a factor that suppress the generation of cells cytotoxic for a syngeneic tumor in DBA/2 mice.
    Levy JG; Maier T; Kilburn DG
    J Immunol; 1979 Mar; 122(3):766-71. PubMed ID: 109502
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Limiting dilution analysis of alloantigen-reactive T lymphocytes. II. Effect of cortisone and cyclophosphamide on cytolytic T lymphocyte precursor frequencies in the thymus.
    Taswell C; MacDonald HR; Cerottini JC
    Thymus; 1979 Sep; 1(1-2):119-31. PubMed ID: 162251
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Limiting dilution analysis of alloantigen-reactive T lymphocytes. VI. Ontogeny of cytolytic T lymphocyte precursors in the thymus.
    Widmer MB; MacDonald HR; Cerottini JC
    Thymus; 1981 Feb; 2(4-5):245-55. PubMed ID: 6453444
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel phenotype associated with in vivo activated CTL precursors.
    Oughton JA; Kerkvliet NI
    Clin Immunol; 1999 Mar; 90(3):323-33. PubMed ID: 10075861
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytotoxic T lymphocyte responses against alloantigens exhibit preferential effector cell activity for H-2K or H-2D region products similar to that for H-2 restricted responses.
    Lucas CJ; Levy RB; Shearer GM
    J Immunol; 1981 Apr; 126(4):1255-9. PubMed ID: 6970767
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ir gene control of the cytotoxic T lymphocyte response to Sendai virus: H-2k mice are low responders to Sendai.
    Shapiro ME; Burakoff SJ; Benacerraf B; Finberg RW
    J Immunol; 1981 Dec; 127(6):2571-4. PubMed ID: 6271873
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of non-H-2 antigens in the cytotoxic T cell response to allogeneic H-2.
    Langhorne J; Lindahl KF
    Eur J Immunol; 1982 Feb; 12(2):101-6. PubMed ID: 6210563
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A glycopeptide extract can inhibit cytotoxic T lymphocyte-target cell conjugation in an H-2-restricted manner.
    Pimlott NJ; Miller RG
    J Immunol; 1984 Oct; 133(4):1763-8. PubMed ID: 6236257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.